First national lockdown
India enters its first nationwide lockdown to slow the initial COVID wave, setting the stage for two large epidemic peaks and a long aftermath.
India saw the world's second-largest COVID wave. Now an estimated 5 million Indians live with Long COVID, chronic fatigue, brain fog and organ damage that persists two years or more after.
Audio version coming soon
India recorded over 4.5 crore confirmed COVID cases through 2024, second only to the United States, with seroprevalence studies suggesting the real infection count was several times higher. WHO defines Long COVID as new or persistent symptoms continuing more than three months after infection that cannot be explained by another diagnosis. ICMR follow-up cohorts and AIIMS post-COVID clinics estimate that between 5 and 10 percent of Indians who had symptomatic COVID develop Long COVID, which translates to a conservative 5 million people. The most common symptoms are profound fatigue, brain fog, breathlessness, palpitations, sleep disturbance, and post-exertional malaise. AIIMS and PGI Chandigarh have set up dedicated post-COVID clinics but most district hospitals do not yet recognise the syndrome. Many patients pass through cardiology, pulmonology, endocrinology and psychiatry before someone names the condition, which adds to delay, cost and emotional distress.
Long COVID arises from a combination of immune, vascular and viral persistence mechanisms now described in peer-reviewed work. Even after the virus clears the upper airway, fragments and chronic inflammation can persist in some patients, driving fatigue, autonomic dysfunction and small-fibre neuropathy. Pre-existing diabetes, hypertension, obesity and untreated depression raise the risk of developing Long COVID, and India has all of these at scale. But India's specific failure has been in surveillance and recognition. National-level Long COVID registries are thin, ICMR's post-COVID cohorts cover only a sliver of the country, and most family physicians are not trained to diagnose the syndrome formally. As a result, women and informal workers are particularly likely to be told their symptoms are psychological or simply seasonal weakness. Without recognition, there is no leave from work, no insurance coverage and limited research. Long COVID is therefore not only a medical question but a policy one about how chronic post-infectious illness is treated by the Indian health system.
Unread picks stay on top. Fresh stories may appear as they are ready โ no extra loading.
India now has 12 million obese children under 19, according to ICMR data. School canteens sell junk food while ultra-processed food advertising targets children.
India collects only 11 million units of blood annually against a need of 15 million. The O-negative shortage is acute, urban blood banks run on single-day reserves, and the rural gap is catastrophic.
India has fewer sports medicine doctors than many US college programs. Cricket and marathons grew fast; specialist care did not, so preventable injuries end careers early.
Biosimilars โ cheaper copies of complex biological drugs โ are worth 50 billion globally. Indian companies are racing to capture that market, threatening to cut the price of cancer and.
Micronutrient gaps hit rich and poor: anaemia stays high, vegetarians often lack B12, and urban adults lack vitamin D. Fortification and better diets can bend the curve if delivery improves.
127 essential medicines are out of stock in government hospitals across 12 states. The shortage hits insulin, antibiotics and cancer drugs. Central procurement failure exposes PM Jan Aushadhi gaps.
Key statistics on Long COVID in India:
Myth 1: Long COVID is just in the mind. Fact: Peer-reviewed Indian and global studies have documented measurable changes in heart rate variability, lung diffusion, cognitive testing and small-fibre nerve function in Long COVID patients. Depression and anxiety can coexist but the underlying syndrome is biological, not imaginary. Dismissing these patients delays treatment of conditions like POTS, myocarditis and dysautonomia.
Myth 2: If I had a mild COVID, I cannot have Long COVID. Fact: Several Indian and international cohorts show that around half of Long COVID patients had mild or even asymptomatic initial illness. Severity of acute infection is a weak predictor of who develops long-term symptoms. Reinfection further raises the risk.
Myth 3: Exercise like before will fix the fatigue. Fact: Long COVID often features post-exertional malaise, where activity makes symptoms worse for days. Standard graded exercise alone can harm such patients. Current expert consensus recommends careful pacing, pulmonary rehabilitation under supervision and autonomic exercises rather than aggressive return to old workouts. Listening to the body's warning signals is essential.
Take Meera Joshi, a 35-year-old school teacher in Pune who recovered from a mild COVID infection in 2022 but spent the next two years with crushing fatigue, palpitations and brain fog. She visited eight specialists and was told repeatedly that her ECG and chest X-ray were normal. In late 2024 a KEM post-COVID clinic diagnosed POTS and small-fibre neuropathy and started her on a structured rehabilitation, salt loading and beta-blocker. She is back to teaching part-time. Her insurance company refused her three-week hospital admission claim. Across India, Long COVID is reshaping working lives. Lancet Regional Health 2023 estimated that hundreds of thousands of Indians of working age have reduced or stopped employment due to post-COVID symptoms. Women face particular dismissal, with many told their symptoms are simply stress or menopause. Children with Long COVID, though fewer, are missing school. The cumulative national impact on productivity, mental health and household income is still being measured.
The bigger meaning of Long COVID is that India has entered the era of mass post-infectious chronic disease and its health system has not yet caught up. The long-term consequence of failing to recognise, study and support Long COVID is millions of working-age Indians quietly losing earning years, families unable to claim insurance, and research lagging behind the curve in a population that contributes significant data globally. The lesson from the UK NICE pathway and Germany's post-COVID rehabilitation programmes is that early multidisciplinary clinics, structured research cohorts and explicit insurance recognition can change outcomes. India must expand AIIMS-style post-COVID clinics to every state, fund a national Long COVID registry, train family physicians, regulate insurance refusals and integrate post-COVID rehab into Ayushman Bharat. Future pandemics, whether viral, bacterial or otherwise, will produce their own long syndromes. The decisions India makes about Long COVID in this decade will set the template for how the country handles chronic post-infectious illness for generations.
Chronology
Follow the arc from background to turning points. On mobile, swipe the cards and use the step rail below; on desktop, use the spine to jump.
India enters its first nationwide lockdown to slow the initial COVID wave, setting the stage for two large epidemic peaks and a long aftermath.
The Delta wave drives unprecedented hospitalisation and mortality. Tens of millions of additional infections occur, many of which seed later Long COVID.
WHO issues a clinical case definition for post COVID-19 condition, the international term for Long COVID, providing a framework for Indian clinics.
ICMR launches structured follow-up of COVID survivors across multiple centres to study long-term symptoms, organ damage and recovery.
AIIMS Delhi opens India's first formally branded multidisciplinary post-COVID clinic, soon followed by PGI Chandigarh, KEM Mumbai and CMC Vellore.
A Lancet Regional Health Southeast Asia paper from India shows 13 percent of hospitalised COVID survivors still report symptoms at one year, anchoring the national debate.
Patient groups and physicians push IRDAI to recognise Long COVID for health insurance claims after multiple denials make headlines.
Step 1/7 events
Understand why it happened, how we got here, and what might come next.